Cronos Group Inc vs GXO Logistics Inc — how do they compare? Cronos Group Inc trades at $2.76 (market cap $1.02B), while GXO Logistics Inc trades at $52.24 (market cap $5.71B). The key difference: GXO Logistics Inc is far larger — about 5.6× Cronos Group Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, GXO Logistics Inc nearer its low. Which is the better fit depends on your goals.
| CRON | GXO | |
|---|---|---|
Market Cap | $1.02B | $5.71B |
Sector | Health | Industrials |
52-Week High | $3.27 | $65.59 |
52-Week Low | $1.95 | $45.52 |
Enterprise Value | $203.29M | $10.88B |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $2.75, showing no change recently. The stock has a mixed technical outlook with a neutral overall signal but bullish moving averages. Fundamentally, revenue grew to $146.59M in 2025, but net income was negative at -$9.45M. Recent news highlights strong Q1 2026 revenue growth of 40% and expansion of its Spinach brand portfolio, though the company faces intense cannabis sector competition.
Outlook is cautious with growth potential from international expansion and market share gains, but profitability remains a challenge. Risks include regulatory uncertainty and competitive pressures. Analyst sentiment is mixed with 60% hold ratings. The stock presents a speculative opportunity for investors betting on continued top-line growth and eventual margin improvement.
GXO Logistics trades at $48.99, down 3.2% today, with a bearish technical outlook despite strong analyst support. The company shows solid revenue growth with Q1 2026 earnings beating expectations at $0.50 per share versus $0.37 expected. Recent partnerships with major retailers and expansion in Europe highlight business momentum, though thin profit margins and competitive pressures from Amazon pose challenges.
Wall Street remains bullish with 16 buy ratings and a $69.33 price target suggesting 41% upside. However, technical indicators signal near-term weakness, and the stock faces execution risks in maintaining growth against industry competition. The upcoming Q2 earnings on August 5 will be critical for validating the positive fundamental trajectory.
Trailing returns across standard periods
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →GXO is the world's largest pure-play contract logistics provider. It offers cutting-edge supply chain solutions, including automated warehousing and fulfillment, for global blue-chip companies.
Read more on GXO →